Clinical Development of Experimental Therapies for Malignant Glioma
Journal Title: Sultan Qaboos University Medical Journal - Year 2011, Vol 11, Issue 1
Abstract
Advances in medical and surgical treatments in the last two to three decades have resulted in quantum leaps in the overall survival of patients with many types of non-central nervous system (CNS) malignant disease, while survival of patients with malignant gliomas (WHO grades 3 and 4) has only moderately improved. Surgical resection, external fractionated radiotherapy and oral chemotherapy, during and after irradiation, remain the pillars of malignant glioma therapy and have shown signifcant benefts. However, numerous clinical trials with adjuvant agents, most of them administered systemically and causing serious complications and side effects, have not achieved a noteworthy extension of survival, or only with considerable deterioration in patients’ quality of life. Signifcant attention was focussed in the last decades on the cell biology and molecular genetics of gliomas. Improved understanding of the fundamental features of tumour cells has resulted in the introduction and increasing clinical use of local therapies, which employ spatially defned delivery methods and tumour-selective agents specifcally designed to be used in the environment of a glioma-invaded brain. Tis review summarises the key fndings of some of the most recent and important clinical studies of locally administered novel treatments for malignant glioma. Several such therapies have shown considerable anti-tumour activity and a favourable profle of local and systemic side effects. Tese include biodegradable polymers for interstitial chemotherapy, targeted toxins administered by convection enhanced delivery, and intra- and peritumourally injected genetically modifed viruses conferring glioma-selective toxicity. Areas of possible improvement of these therapies and essential future developments are also outlined.
Authors and Affiliations
Nikolai G Rainov| Department of Neurosurgery, Klinikum Augsburg, D-86156 Augsburg, Germany, Volkmar Heidecke| Department of Neurosurgery, Klinikum Augsburg, D-86156 Augsburg, Germany
Keywords
Related Articles
- EP ID EP14015
- DOI -
- Views 326
- Downloads 11
Eccrine Syringofbroadenoma of the Eyelid
Sporadic Lateral Ventricular Hemangioblastoma presenting with Intraventricular and Subarachnoid Haemorrhage
Intraventricular hemangioblastoma (HB) is very rare; few cases of intraventricular HB have been reported in the literature, either sporadically or in association with von Hippel-Lindau disease. Furthermore, the inciden...
Sigmoid Volvulus Complicating Pregnancy Managed by Resection and Primary Anastomosis Case report with literature review
Sigmoid volvulus is an extremely rare cause of intestinal obstruction in pregnancy. Te rarity of the condition and the fact that pregnancy itself clouds the clinical picture invariably leads to a delay in diagnosis with...
Clinical Teachers’ Opinions about Bedside-based Clinical Teaching
Objectives: In recent years, there has been a decline in estimated time spent on bedside teaching. Te aim of this study was to evaluate clinical teachers’ perceptions and practice of, and approaches to, bedside teach...
A Missed Late Presentation of a Congenital Pulmonary Airway Malformation as a Large Infected Bulla
A congenital pulmonary airway malformation (CPAM) is a rare cystic anomaly that may occur during development of the fetal airways. The vast majority of CPAMs are detected in neonates; as such, it is unusual for diagnosis...